Skip to main content

Table 1 Distribution of TnT by relevant covariates at baseline

From: The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients

Covariate

High sensitivity Troponin T, ng/L

p-value*

<5.0 (n = 95)

5.0–13.9 (n = 114)

≥14.0 (n = 66)

Age, years, mean (SD)

62 (7.3)

64 (6.7)

67 (7.2)

<0.001

Female, n (%)

64 (67)

56 (49)

26 (39)

<0.001

BMI, mean (SD)

24.7 (5.1)

24.7 (5.4)

24.5 (5.4)

0.962

GOLD class III/IV, n (%)

46 (48)

60 (53)

51 (77)

0.001

Hypertension, n (%)

32 (34)

36 (32)

36 (55)

0.006

Diabetes, n (%)

4 (4)

1 (1)

9 (14)

0.001

Current smoking, n (%)

34 (36)

29 (26)

11 (17)

0.025

Pack years, mean (SD)

35 (16.1)

35 (16.9)

37 (19.5)

0.686

Systolic BP, mmHg mean (SD)

132 (21.9)

138 (20.1)

138 (19.5)

0.080

Hemoglobin, g/dL mean (SD)

14.1 (1.2)

14.3 (1.1)

15.7 (13.7)

0.285

Heart rate per min, mean (SD)

70 (13.3)

71 (12.9)

75 (13.9)

0.067

LVH, n (%)

1 (1)

5 (5)

2 (3)

0.358

Pathologic Q-wave, n (%)

5 (5)

6 (5)

9 (14)

0.067

Use of antiplatelet therapy, n (%)

10 (10)

12 (11)

5 (8)

0.781

PaO2, kPa, mean (SD)

9.0 (1.1)

9.3 (1.3)

8.9 (1.3)

0.058

PaCO2, kPa, mean (SD)

5.4 (0.7)

5.4 (0.8)

5.5 (0.8)

0.847

Leucocytes, x109/L, mean (SD)

7.0 (1.7)

7.1 (1.9)

7.8 (2.3)

0.028

GFR, mL/min, mean (SD)

89 (3)

89 (3)

79 (4)

0.044

6MWD, meters, mean (SD)

465 (109)

455 (123)

365 (104)

<0.001

mMRC >2, n (%)

42 (44)

58 (51)

47 (71)

0.003

AECOPD during last year, n (%)

33 (35)

40 (36)

28 (43)

0.571

  1. *Analysis of variance, Pearson Chi-Square, Fisher’s exact test, as appropriate